Mather Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.92M | Buy |
4,316
+170
| +4% | +$75.7K | 0.02% | 196 |
|
|
2025
Q1 | $2.01M | Buy |
4,146
+259
| +7% | +$126K | 0.02% | 182 |
|
|
2024
Q4 | $1.57M | Sell |
3,887
-128
| -3% | -$51.5K | 0.02% | 186 |
|
|
2024
Q3 | $1.87M | Buy |
4,015
+80
| +2% | +$37.2K | 0.02% | 170 |
|
|
2024
Q2 | $1.64M | Buy |
3,935
+398
| +11% | +$166K | 0.02% | 209 |
|
|
2024
Q1 | $1.44M | Sell |
3,537
-104
| -3% | -$42.3K | 0.02% | 179 |
|
|
2023
Q4 | $1.48M | Buy |
3,641
+49
| +1% | +$19.9K | 0.02% | 181 |
|
|
2023
Q3 | $1.25M | Buy |
3,592
+422
| +13% | +$147K | 0.02% | 186 |
|
|
2023
Q2 | $1.12M | Buy |
3,170
+287
| +10% | +$101K | 0.02% | 214 |
|
|
2023
Q1 | $908K | Hold |
2,883
| – | – | 0.02% | 223 |
|
|
2022
Q4 | $833K | Buy |
2,883
+102
| +4% | +$29.5K | 0.02% | 235 |
|
|
2022
Q3 | $805K | Buy |
2,781
+231
| +9% | +$66.9K | 0.02% | 226 |
|
|
2022
Q2 | $719K | Buy |
2,550
+264
| +12% | +$74.4K | 0.02% | 211 |
|
|
2022
Q1 | $596K | Buy |
+2,286
| New | +$596K | 0.01% | 233 |
|